NCT00028873View on ClinicalTrials.gov

R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

June 30, 2002

Conditions
Breast Cancer
Interventions
DRUG

docetaxel

DRUG

laniquidar

DRUG

paclitaxel

Trial Locations (2)

44805

CRLCC Nantes - Atlantique, Nantes-Saint Herblain

B-1000

Institut Jules Bordet, Brussels

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00028873 - R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy | Biotech Hunter | Biotech Hunter